Constitutive activation of nuclear factor-κB (NF-κB) in cancer treatment induces tumor promotion, angiogenesis, metastasis, apoptosis, and resistance to anticancer drugs (Garg and Aggarwal, 2002; Pikarsky et al., 2004). This evidence concerns the gene NFKB1 and cancer.